T Hitzeroth

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
224 patients with coronary heart disease, hypertension, disturbances of cardiac rhythm or hyperkinetic heart syndrome were treated with the cardioselective beta-blocker Talinolol (Cordanum) for a period up to 3 years. In 239 examinations in intravenous or peroral application of this medicament we controlled among others the appearance of side effects. This(More)
  • 1